Jump Financial’s Axsome Therapeutics AXSM Stock Holding History

Jump Financial’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Buy	+4,189	New	+$908K	0.01%	1180
2025 Q4	–	Sell	-25,000	Closed	-$3.04M	–	1934
2025 Q3	$3.04M	Sell	25,000 -103,500	-81%	-$11.7M	0.04%	569
2025 Q2	$13.4M	Buy	128,500 +35,860	+39%	+$3.8M	0.15%	172
2025 Q1	$10.8M	Buy	+92,640	New	+$10.6M	0.14%	170
2024 Q4	–	Sell	-9,080	Closed	-$816K	–	1642
2024 Q3	$816K	Sell	9,080 -18,039	-67%	-$1.57M	0.02%	884
2024 Q2	$2.18M	Buy	+27,119	New	+$2.01M	0.04%	515
2024 Q1	–	Sell	-8,400	Closed	-$669K	–	1896
2023 Q4	$669K	Buy	+8,400	New	+$562K	0.02%	906
2023 Q3	–	Sell	-8,488	Closed	-$610K	–	1844
2023 Q2	$610K	Sell	8,488 -51,503	-86%	-$3.8M	0.02%	932
2023 Q1	$3.7M	Buy	59,991 +27,241	+83%	+$1.79M	0.15%	217
2022 Q4	$2.53M	Sell	32,750 -4,636	-12%	-$277K	0.13%	202
2022 Q3	$1.67M	Buy	+37,386	New	+$1.87M	0.06%	432
2021 Q2	–	Sell	-12,500	Closed	-$708K	–	1077
2021 Q1	$708K	Buy	+12,500	New	+$879K	0.07%	311

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jump Financial's AXSM Position: Q2 2026 in Review

Jump Financial opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 4,189 shares worth $1.03M. The stake represents 0.01% of the portfolio and ranks #1180 among its holdings. This is a return to the name: Jump Financial previously reported a position in AXSM as recently as Q3 2025.

Jump Financial first reported a position in AXSM in Q1 2021 and has held it in 12 quarters since. The position peaked at $13.4M in Q2 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Jump Financial held 4,189 shares of Axsome Therapeutics worth $1.03M as of Q2 2026.
Axsome Therapeutics was a new Jump Financial position in Q2 2026.
Axsome Therapeutics made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1180 holding.
Jump Financial first reported a position in Axsome Therapeutics in Q1 2021 and has held it in 12 quarters since.
Jump Financial's Axsome Therapeutics position peaked at $13.4M in Q2 2025.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.